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ABSTRACT 
Effects of ETB receptor stimulation and its subcellular pathways were evaluated in 
carbachol pre-contracted rabbit iris sphincter muscles (n=51). ETB stimulation with 
sarafotoxin (SRTX-c; 10-10–10-6M) was tested in the absence (n=7) or presence of 10-
5M of: BQ-788 (ETB2 receptor antagonist; n=6), L-NA (NOS inhibitor; n=7) or 
indomethacin (ciclooxygenase inhibitor; n=10). Effects of ETB stimulation by 
endothelin-1 (ET-1; 10-10–10-7M) in presence of an ETA receptor antagonist (BQ-123; 
10-5M; n=7) and of ETB1 stimulation by IRL-1620 (10-10–10-7M; n=7) were also tested. 
Finally, the effects of SRTX-c (10-9–10-7M) in electric field stimulation (EFS) 
contraction were evaluated (n=7). ETB receptor stimulation by SRTX-c or ET-1 in 
presence of BQ-123 promoted a concentration-dependent relaxation of the rabbit iris 
sphincter muscles averaging 10.8±2.0% and 9.4±1.8%,respectively. This effect was 
blocked by BQ-788 (-2.3±2.0%), L-NA (4.5±2.3%) or indomethacin (2.3±2.9%). 
Selective ETB1 stimulation by IRL-1620 did not relax the iris sphincter muscle 
(0.9±5.4%). EFS elicited contraction was not altered by SRTX-c. In conclusion, ETB 
receptor stimulation relaxes the carbachol pre-contracted iris sphincter muscle, an effect 
that is mediated by the ETB2 receptor subtype, through NO and prostaglandins release. 
 
 
Keywords: peptide hormones, iris, muscle fibers, ETB2, sarafotoxin-s6c 
 
Abbreviations: SRTX-c: Sarafotoxin s6c; ET –Endothelin; ETA: Endothelin receptor 
type A; ETB : Endothelin receptor type B;  COX – ciclooxygenase; NO: nitric oxide. 
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INTRODUCTION 
 
Endothelin-1 (ET-1) is an endogenous vasoactive peptide with 21 aminoacids, 
secreted by vascular endothelial cells (Yanagisawa, M. et al. 1989, Yanagisawa, M. et 
al. 1988). ET-1 is a member of related peptides family, which includes endothelin-2 
(ET-2), endothelin-3 (ET-3), sarafotoxin-s6c (SRTX-c) and vasoactive intestinal 
contractors. This peptide promotes potently the contraction of both vascular and non-
vascular smooth muscles (Eglen, R. M. et al. 1989). 
 In humans, the 3 isoforms of ET mediate their biological actions by two 
different receptors, ETA and ETB (Arai, H. et al. 1990, Inoue, A. et al. 1989, Sakurai, T. 
et al. 1990)The ETA receptor, located on vascular smooth muscle, mediates a potent 
vasoconstrictor action, promotes miosis and mitogenesis, and binds preferably to 
ET-1(Masaki, T. 1991), while the ETB receptor binds equi-potently the three isoforms 
and mediates vasodilatation and ocular hypotension (Haque, M. S. et al. 1995), probably 
through stimulation of nitric oxide and prostaglandins release (Inoue, A. et al. 1989, 
Masaki, T. 1991). This receptor has two isotypes: ETB1 or endothelial, and ETB2 or 
muscular (Nishiyama, M. et al. 1995, Sudjarwo, S. A. et al. 1994). Another receptor, the 
ET-C receptor, cloned from Xenopus melanophores has greater affinity for ET-3 than 
for ET-1 and ET-2 (Karne, S. et al. 1993, Yorio, T. et al. 2002). 
Endothelin-1 is widely distributed in mammalian ocular tissues including 
cornea, ciliary body epithelium and retina (Ripodas, A. et al. 2001, Yorio, T. et al. 
2002). ET-1 mRNA was identified by in situ hybridization in human ciliary body, 
ciliary muscle, constrictor of iris sphincter, stroma and iris vessels. ET-1 was detected 
in aqueous humour, endothelial and non pigmented ciliary epithelium (Fernandez-
Durango, R. et al. 2003). In terms of ET receptors expression in the human iris, almost 
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2/3 of them are of the ETB subtype (Fernandez-Durango, R. et al. 2003). The iris is the 
main expressing tissue of ET receptors, followed by the ciliary muscle and ciliary 
processes (Fernandez-Durango, R. et al. 2003). Immunoreactivity studies detected ET-3 
in the retina (De Juan, J. A. et al. 1995). In the iris of the pig and cat eyes, ET produces 
a concentration dependent contraction mediated by the ETA receptor subtype (Geppetti, 
P. et al. 1989). When injected in the posterior compartment of the eye, ET promotes 
iNOS stimulation, ischemia of optic nerve and lowering of axonal transport, with 
destruction of optic nerve and increase of intraocular pressure (IOP) (Yorio, T. et al. 
2002). ET administration in the eye’s anterior segment reduces IOP, independently of 
prostaglandin production (Haque, M. S. et al. 1995). Also the production of aqueous 
humour is affected by ET-1, which inhibits the NA+/K+ ATPase (Prasanna, G. et al. 
2001). 
The aim of this work was to determine the role of ETB receptor stimulation in 
the modulation of iris sphincter muscle contraction, its sub-cellular pathways and the 
ETB receptor subtype involved. 
 
METHODS 
All animal procedures were performed in accordance with the ARVO statement 
for the Use of Animals in Ophthalmic and Vision Research. 
 
FUNCTIONAL STUDIES 
Specimens preparation 
The study was performed in isolated iris sphincter (n=51) muscles from male 
New Zealand white rabbits (Oryctolagus cuniculus; 2.0-3.0Kg). Animals were 
euthanized after an injection of pentobarbital sodium salt (50 mg/kg) into the marginal 
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ear vein. The eyes were immediately enucleated and placed in modified Krebs-Ringer 
(KR) solution at 35 ºC, with the following composition in mM: NaCl 98; KCl 4.7; 
MgSO4.7H2O 2.4; KH2PO4 1.2; glucose 4.5; CaCl2.2H2O 2.5; NaHCO3 17; C3H3NaO3 
15 and CH3COONa 5. After removal of the cornea, the iris sphincter muscle was 
quickly excised and immersed in the KR solution. After dissection, the ends of each 
piece were tied with silk thread for mounting in a 15 ml plexi glass organ bath 
containing the above-described solutions.  One end of the specimen was connected to an 
electromagnetic length-tension transducer (University of Antwerp, Belgium), and the 
other was secured to a clip at the wall of the organ bath. All the surgical procedures 
were taken under microscope (Zeiss, Stemi 2000C, Germany). Solutions were bubbled 
with 95% O2 and 5% CO2 and pH was maintained between 7.38-7.42. 
Iris sphincter muscles were stabilized always at the same preload (1.0 mN) and 
bathing solutions were continuously replaced until muscle length stabilization. They 
were then switched to isometric conditions and the protocols initiated when muscle 
tension stabilized. 
 
Experimental protocols 
Effect of ETB stimulation on the pre-contracted iris sphincter muscle  
After stabilization, the rabbit iris sphincter muscles were contracted by adding carbachol 
(10-6 M) to the organ bath. The effects of ETB receptor stimulation on the pre-contracted iris 
sphincter muscle were studied by evaluating its response to: (i) the ETB agonist SRTX-c 
(10-10–10-6M; n=7), (ii) Endothelin-1 (ET-1;10-10–10-7 M; n=7) in the presence of an ETA 
receptor antagonist (BQ-123; 10-5 M) (iii) the selective ETB1 agonist IRL-1620 (10-10–10-7 
M; n=7). Furthermore, the response to SRTX-c (10-10–10-6M) was also assessed in the 
presence of: (i) an ETB2 receptor antagonist, BQ-788 (10-5 M; n=6); (ii) a NO synthase 
inhibitor, L-nitro-L-arginine (L-NA; 10-5 M; n=7); (iii) a ciclooxygenase inhibitor, 
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indomethacin (indo; 10-5 M; n=10). In each muscle, two carbachol-induced contractions 
were studied. One of these contractions was randomly selected to test the effects of the 
drugs to be studied, while the other one was used as control, having been studied in the 
presence of the vehicle solution alone. In each protocol, each concentration was added to 
the bath solution only after recording the maximal effect of the previous one.  
 
 
Effect of ETB stimulation on the EFS elicited contraction 
After stabilization, rabbit iris sphincter muscles (n=7) were contracted by placing them 
in an electric field stimulation of 10V, 5 Hz and 1 ms duration. Developed tension was 
recorded in 5 consecutive, 3 minutes apart, contractions. After completing the 
acquisition in baseline conditions, SRTX-c (10-9) was added to the organ bath and a new 
electric field stimulation elicited 15 minutes later. The drug was then washed out and a 
new control contraction obtained.  After that, the second concentration of SRTX-c (10-8) 
was added to the bath and a new electric field stimulation elicited 15 minutes later. The 
procedure was then repeated to test the concentration of 10-7 M. Finally, the drug was 
washed out again and another control contraction was obtained to confirm the 
preservation of muscle performance. 
 
Materials  
All chemicals were obtained from Sigma Chemical Co (St Louis, Mo). Peptides were 
prepared in aliquots and stored at -20ºC. 
 
STATISTICAL ANALYSIS 
Data presented as means±SEM. EFS-elicited contractions, in presence and 
absence of SRTX-c, were compared with a paired Student’s t-test. Concentration-
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response curves of SRTX-c in carbachol pre-contracted muscles in each experimental 
condition were evaluated with one-way repeated measures ANOVA. Effects of each 
dose of drug in different experimental conditions were tested with one-way ANOVA. 
When significant differences were detected with any of the ANOVA test, the Student-
Newman-Keuls test was selected to perform multiple comparisons. P<0.05 was 
accepted as significant.  
 
RESULTS 
Effect of ETB stimulation on the carbachol elicited contraction of the iris sphincter 
muscle 
Active tension of the iris sphincter muscle preparations elicited by the addition 
of carbachol (10-6M) to the bath was quite stable, not significantly different between the 
different protocols and similar in control and test contractions, averaging 2.99±0.10 
mN. 
Addition of SRTX-c to the pre-contracted iris sphincter muscle promoted a 
19.1±2.6% decrease of the active tension, while the in the control contraction it 
decreased 8.3±2.0% (p<0.05), over the same period of time (figure 1; upper panel). 
ETB receptor stimulation by ET-1 in presence of BQ-123 decreased active 
tension by 16.4±1.8%, while the control contraction decreased only 9.02±2.8 % 
(p<0.05), over the same period of time (figure 1; lower panel). 
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Figure 1 
 
 
 
 
On the contrary, selective ETB1 receptor stimulation either by IRL-1620 or by 
SRTX-c in presence of BQ-788 (figure 2) did not promote a decline in active tension 
significantly different from the control contraction in the presence of the vehicle alone. 
Figure 2 
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To test the influence of prostaglandins and NO in ETB induced relaxation of 
carbachol-induced contraction of the iris sphincter muscle, increasing concentration of 
SRTX-c were tested in the presence of indomethacin or L-nitro-L-arginine (L-NA). 
While indomethacin completely inhibited the relaxing effect of SRTX-c (figure 3; upper 
panel), L-NA only attenuated such effect at concentrations of SRTX-c equal or higher 
than 10-7M. 
 
Figure 3 
 
 
Effect of ETB stimulation on the EFS elicited contraction 
Active tension of the iris sphincter muscle preparations elicited by the EFS was 
quite stable not significantly different between the different protocols and similar in 
control and test contractions, averaging 0.45±0.02 mN. The presence of SRTX-c in the 
bath (10-9–10-7M) did not promote any change in muscle tension, elicited by the electric 
field stimulation (figure 4). 
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Figure 4 
 
 
 
 
DISCUSSION 
The present study described the relaxation of the pre-contracted iris sphincter 
muscle promoted by ETB receptor stimulation. Interestingly, this effect is mediated by 
the ETB2 receptor subtype through prostaglandins and NO release. 
In the rat, ETA receptor stimulation contracts the iris sphincter muscle and 
potentiates its electric field elicited contraction (Shinkai, M. et al. 1994). In the same 
experimental preparation, Shinkai-Goromaru and collaborators reported a 140% 
increase of electric field stimulation developed tension, in response to ETB receptor 
stimulation by SRTX-c (Shinkai-Goromaru, M. et al. 1997). In these conditions, ETB 
receptor stimulation increased acetylcholine release in the pre-junctional site of the 
cholinergic synapses. This finding is quite relevant as ET-3, which has a similar affinity 
for ETA and ETB receptors, is more abundant in the iris than ET-1 (Fernandez-Durango, 
R. et al. 2003, Shinkai-Goromaru, M. et al. 1997). On the contrary, in our work, ETB 
receptor stimulation promoted relaxation of the carbachol pre-contracted iris sphincter 
muscle. This was observed in response to either SRTX-c or ET-1 in presence of BQ-
123, an ETA receptor blocker. This observation suggests that the effects of ETB 
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stimulation are distinct in carbachol and EFS elicited contractions. However, in our 
study the latter was not affected by SRTX-c (10-9–10-7M), suggesting that, contrary to 
the rat, in the rabbit ETB receptor stimulation does not increase acetylcholine release. 
 
Table 1- Effects of ETB stimulation and its subcellular pathway in the iris sphincter 
muscle 
 
∆ TENSION  
(% vs control) 
p<0.05 
 
SRTX-c -10.8 ± 2.03 % 
 vs control 
ET1+BQ123 -9.35 ± 1.79 % vs control 
IRL-1620 -0.91 ± 5.45 % vs SRTX-c; ET-1 
SRTX-c + BQ-788 2.30 ± 2.04 % vs SRTX-c; ET-1 
SRTX-c + LNA -4.46 ± 2.28 % vs SRTX-c 
SRTX-c + Indo -2.55 ± 3.00 % vs SRTX-c 
 
 
The presence, in the muscle and endothelium, of two functionally distinct ETB 
receptors (ETB1 and ETB2) was initially described in the swine pulmonary vein 
(Sudjarwo, S. A. et al. 1993). Later, additional evidences of the existence of two ETB 
receptor subtypes were reported in the rabbit venous saphenous muscle (Nishiyama, M. 
et al. 1995), in the tracheal smooth muscle (Yoneyama, T. et al. 1995),  in the rabbit 
basilar artery (Zuccarello, M. et al. 1999), in the guinea pig ileum (Miasiro, N. et al. 
1999) and in the rabbit heart (Leite-Moreira, A. F. and C. Bras-Silva 2004).  The ETB2 
receptor subtype promotes contraction of the swine pulmonary vein (Sudjarwo, S. A. et 
al. 1993), the rabbit saphenous vein (Nishiyama, M. et al. 1995), the rabbit basilar artery 
(Zuccarello, M. et al. 1999) and in the tracheal smooth muscle (Yoneyama, T. et al. 
1995). It has a biphasic effect, i.e. relaxation followed by contraction, on the guinea pig 
ileum (Miasiro, N. et al. 1999, Miasiro, N. et al. 1998), and increases myocardial 
inotropy in the rabbit heart (Leite-Moreira, A. F. and C. Bras-Silva 2004). SRTX-c acts 
preferentially in the ETB2 receptor subtype, while IRL-1620 selectively stimulates the 
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ETB1 subtype (Karaki, H. et al. 1994a, Karaki, H. et al. 1994b, Sudjarwo, S. A. et al. 
1993, Sudjarwo, S. A. et al. 1994, Yoneyama, T. et al. 1995). In our study, we observed 
that SRTX-c, but not IRL-1620 relaxed the carbachol pre-contracted muscle, an effect 
that was blocked by BQ-788. These findings suggest that the receptor subtype involved 
in ETB induced iris sphincter relaxation is the ETB2. The effect of SRTX-c on ETB2-
induced rabbit vein contraction was also previously shown to be inhibited by BQ-
788(Karaki, H. et al. 1994a). Interestingly, however, the iris sphincter was the first 
muscle where a relaxing instead of a contracting effect was described in response to 
ETB2 receptor stimulation. 
The relaxing effect of ETB2 stimulation was dependent of prostaglandins and 
NO. These agents also mediate the negative inotropic (Leite-Moreira, A. F. and C. Bras-
Silva 2004) and the venous vasodilatory (De Nucci, G. et al. 1988, Filep, J. G. et al. 
1991, Hirata, Y. et al. 1993) effects induced by ETB1 receptor stimulation. 
Prostaglandins and their receptors are widely distributed in the ocular tissues, including 
the iris sphincter muscle. The EP2 receptor is the most abundant in rabbit 
(Bhattacherjee, P. et al. 1993, Csukas, S. et al. 1992), mouse and human iris (Biswas, S. 
et al. 2004). In human eyes, FP, DP and EP receptors were localized in the ciliary body 
and iris, being particularly involved in the IOP regulation (Davis, T. L. and N. A. Sharif 
1999, Sharif, N. A. et al. 2004, Sharif, N. A. et al. 2000). 
FP-receptors agonists promoted phosphoinositide (PI) hydrolysis, mitogen-
activated protein kinase (MAPK) activation and myiosin light chain phosphorylation 
causing Ca2+ mobilization and iris contraction (Ansari, H. R. et al. 2004, Sharif, N. A. et 
al. 2008). On the other side,  EP2, EP4 and DP receptors activation produces 
intracellular cAMP accumulation and muscle relaxation (Abdel-Latif, A. A. 2001). In 
our preparation, prostaglandins released by ETB2 stimulation partially reverse the 
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carbachol-induced contraction. Further investigations are needed to indentify the 
subcellular pathway of this effect. 
The blockage of endogenous NO production also inhibited SRTX-c induced 
relaxation. However, in contrast to prostaglandins that mediated relaxation over the 
entire concentration-response curve, NO dependence was only evident for 
concentrations of SRTX-c higher than 10-7 M. In the bovine iris muscle, a non-
adrenergic, non-cholinergic system (Pianka, P. et al. 2000) was shown to promote a NO 
dependent relaxation. NO release can occur directly from nitrergic neurons (Wiencke, 
A. K. et al. 1994) or in response to substances such as adrenomedullin that promote its 
synthesis (Uchikawa, Y. et al. 2005).  
This relaxing effect adds to other ETB receptor mediated effects in ocular 
tissues, such as the relaxation of the bovine ciliary muscle (Kamikawatoko, S. et al. 
1995) and the ocular hypotensive effect (Haque, M. S. et al. 1995). In conjunction with 
ET-3 levels in the iris and ciliary tissues and with ET-1 levels in exfoliation syndrome  
patients (Koliakos, G. G. et al. 2004) our results highlight the importance of endothelin 
(and ETB pathway) as a regulator of the iris muscles. 
 
 
 
FIGURE LEGENDS 
Figure 1. Concentration-response curves of SRTX-c (10-10–10-6M; upper panel) and 
ET-1 (10-10–10-7M) in the presence of BQ-123 (10-5M; lower panel) elicited tension 
decrease in carbachol pre-contracted iris sphincter muscles. Control lines refer to 
recordings in presence of the vehicle alone. p<0.05: * vs. control. 
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Figure 2. Concentration-response curves of SRTX-c (10-9–10-6M) in presence of BQ-
788 (10-5M; upper panel) and IRL-1620 (10-10–10-7M; lower panel) elicited tension 
decrease in carbachol pre-contracted iris sphincter muscles. Control lines refer to 
recordings in presence of the vehicle alone. p<0.05: * vs. control. 
 
Figure 3. Concentration-response curves of SRTX-c (10-9–10-6M) in presence of 
indomethacin (upper panel; 10-5M) or L-nitro-L-Arginine (lower panel; 10-5M) elicited 
tension decrease in carbachol precontracted iris sphincter muscles. Control lines refer to 
recordings in presence of the vehicle alone. p<0.05: * vs. control. 
 
Figure 4. Graphic representation of tension development in response to two consecutive 
EFS group of contractions in the absence or presence of SRTX-c (10-9–10-7M).  
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